Cantor Fitzgerald Reiterates Overweight Rating for Tenet Healthcare (NYSE:THC)
Tenet Healthcare (NYSE:THC – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They presently have a $104.00 target price on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 2.12% from the company’s current price. Other research […]
More Stories
West Oak Capital LLC Acquires 3,109 Shares of iShares Core S&P 500 ETF (NYSEARCA:IVV)
West Oak Capital LLC raised its holdings in iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 287.6% in...
Progyny (NASDAQ:PGNY) Shares Up 3.1% – Should You Buy?
Progyny, Inc. (NASDAQ:PGNY – Get Free Report)’s stock price shot up 3.1% on Wednesday . The stock traded as high...
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6.7% – Here’s What Happened
Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) traded down 6.7% on Wednesday . The company traded...
PayPal (NASDAQ:PYPL) Shares Down 0.3% – Here’s Why
PayPal Holdings, Inc. (NASDAQ:PYPL – Get Free Report)’s stock price traded down 0.3% during mid-day trading on Wednesday . The...
Invesco QQQ (NASDAQ:QQQ) Stock Price Up 0% – Here’s Why
Invesco QQQ (NASDAQ:QQQ – Get Free Report)’s share price shot up 0% during mid-day trading on Wednesday . The stock...
Ecor1 Capital, Llc Purchases 21,021 Shares of Zymeworks Inc. (NYSE:ZYME) Stock
Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 21,021 shares of Zymeworks stock in a transaction...